Vaccine Lab / Alfa Chemistry
Dengue Virus Serotype 1 Virus-Like Particles (Gen.2)

Dengue Virus Serotype 1 Virus-Like Particles (Gen.2)

Product Name: Dengue Virus Serotype 1 Virus-Like Particles (Gen.2)
Catalog Number: ACVL-VLP003
Category: Virus-Like Particles (VLPs)
Host System: HEK293 Stable Cell Line (Mammalian)
Components: Envelope (E), pre-Membrane (prM), Membrane (M)

Product Overview

Dengue Virus Serotype 1 VLP (Gen.2) represents an advanced recombinant antigen system developed to address reproducibility and scalability challenges in flavivirus research. Built on a stably transfected HEK293 cell line, this platform enables continuous and controlled production of virus-like particles with reduced batch variability.

The resulting particles maintain key structural characteristics of DENV-1 surface proteins while offering a more consistent manufacturing profile, making them suitable for studies requiring standardized materials across multiple experimental cycles.

Product Advantages

  • Stable Expression System

Integration of expression constructs into the host genome ensures long-term, uniform protein production.

  • Enhanced Batch Consistency

Minimized variation between production lots supports reproducible experimental outcomes.

  • Scalable Manufacturing Capability

Adaptable to larger culture volumes, facilitating preclinical and process development workflows.

  • Reliable Antigen Quality

Maintains conformational integrity of viral proteins while improving production robustness.

Technical Specifications

ItemSpecification
Product NameDengue Virus Serotype 1 Virus-Like Particles (Gen.2)
Catalog NumberACVL-VLP003
Expression SystemHEK293 stable mammalian cell line
ComponentsEnvelope (E), pre-Membrane (prM), and Membrane (M)
Sequence ReferenceNCBI Accession ACA48859.1
FormulationProvided in optimized buffer for maximum stability

Applications

  • Preclinical Vaccine Development: Supports evaluation of vaccine candidates requiring consistent antigen input.
  • Assay Standardization: Provides a reliable antigen source for assay validation and cross-study comparison.
  • Neutralizing Antibody Analysis: Suitable for quantitative and comparative antibody studies.
  • Process Development: Applicable in upstream/downstream optimization and analytical method development.

Product Positioning

This second-generation VLP is optimized for scale-up research, assay standardization, and translational studies, where reproducibility and supply stability are critical.

In addition to DENV-1 VLP (Gen.2), Alfa Chemistry also offers virus-like particles representing Dengue Virus Serotypes 2, 3, and 4, supporting multivalent vaccine research and comparative flavivirus studies.

Our products and services are for research use only and cannot be used for any clinical purposes.

Online Inquiry
Verification code